Boston Scientific Corporation vs Johnson & Johnson — Stock Comparison
Q·Score Breakdown
8.7
Very Bullish
Overall
7.1
Bullish
Quality
Health
Growth
Valuation
Sentiment
BSX
Clean balance sheet with low leverage (0.4× debt-to-equity).
JNJ
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
Analyst Consensus
BUY
Target $85.19 (+50.8%)
32 analysts
BUY
Target $252.42 (+11.1%)
24 analysts
Fundamentals
BSX
JNJ
23.6×
Trailing P/E
26.3×
15.0×
Forward P/E
17.9×
17.3%
Profit Margin
21.8%
68.9%
Gross Margin
68.0%
14.7%
ROE
26.4%
11.6%
Revenue Growth
9.9%
100.0%
Earnings Growth
-52.9%
0.78
Beta
0.33
—
Price / Book
—
$84.0B
Market Cap
$546.9B
$56 – $110
52-Week Range
$146 – $252
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →